Research Papers

25 of 553 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Therapeutic benefits of quercetin in traumatic brain injury model exposed to cigarette smoke.
Alqahtani F; Mohamed Ali YS; Almutairi MM; Alotaibi AF; Imran I; Alshammari MA; Alshememry AK; AlSharari SD; Albekairi TH.
Saudi Pharm J (Unknown)
Published: 2023
4/6 Transparent
Data Funding Declared
Oxyphenbutazone ameliorates carfilzomib induced cardiotoxicity in rats via inhibition of oxidative free radical burst a…
Imam F; Afzal M; Ghaboura N; Saad Alharbi K; Kazmi I; Alshehri S; Saeed Alqarni S; Guven E.
Saudi Pharm J (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Therapeutic potentials of iridoids derived from Rubiaceae against in vitro and in vivo inflammation: A scoping review.
Jaafar A; Zulkipli MA; Mohd Hatta FH; Jahidin AH; Abdul Nasir NA; Hazizul Hasan M.
Saudi Pharm J (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
A survey of drive-thru pharmacy services: Evaluating the acceptance and perspectives of community pharmacists in Saudi …
Asiri IM; Alrastal DY; Alaqeel RK; Alotaibi FM; Kurdi SM; Alshayban DM; Alsultan MM; Almalki BA; AlShehail BM; ALZlaiq WA; Alotaibi MM; Alanazi MS.
Saudi Pharm J (Unknown)
Published: 2023
2/6 Transparent
Development of progesterone electrospun nanofibers to coat Arabin pessaries as a dual preventive and therapeutic approa…
Almousained MM; Alshehri AA; Aodah AH; Alhindi YM; Alqahtani SH; Alfassam HA; Almomen A; Tawfik EA.
Saudi Pharm J (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Targeting inflammation and oxidative stress for protection against ischemic brain injury in rats using cupressuflavone.
Albaqami FF; Abdel-Rahman RF; Althurwi HN; Alharthy KM; Soliman GA; Aljarba TM; Ogaly HA; Abdel-Kader MS.
Saudi Pharm J (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Appropriateness of anticoagulation level in older adult patients on Warfarin: A multicenter retrospective study.
Badawoud AM; Alanizi A; Alnakhli AO; Alzahrani W; AlThiban HS; AlKhurayji RW; Alnakhli AM; Alamoudi JA; Al Yami MS.
Saudi Pharm J (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Mechanistic insight into the synergistic antimicrobial potential of <i>Fagonia indica</i> Burm.f. extracts with cefixim…
Abrar A; Zafar A; Fatima M; Muntaqua D; Naz I; Fatima H; Ul Haq I.
Saudi Pharm J (Unknown)
Published: 2023
4/6 Transparent
Data Funding Declared
Isolation of a novel isoprenylated phenolic compound and neuroprotective evaluation of <i>Dodonaea viscosa</i> extract …
Almarfadi OM; Siddiqui NA; Shahat AA; Fantoukh OI; El Gamal AA; Raish M; Bari A; Iqbal M; Alqahtani AS.
Saudi Pharm J (Unknown)
Published: 2023
4/6 Transparent
Data Funding Declared
Assessing the validity and reliability of the Arabic versions of Mini Asthma Quality of life questionnaire and Asthma C…
Al-Qerem W; Jarab A; Bawab AQA; Hammad A; Ling J; Alasmari F; Oweidat KA; Ibrahim S.
Saudi Pharm J (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Implication of MAPK, Lipocalin-2, and Fas in the protective action of liposomal resveratrol against isoproterenol-induc…
Alhusaini AM; Alshehri SM; Sarawi WS; Alghibiwi HK; Alturaif SA; Al Khbiah RA; Alali SM; Alsaif SM; Alsultan EN; Hasan IH.
Saudi Pharm J (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
The influence of telemedicine in primary healthcare on diabetes mellitus control and treatment adherence in Riyadh regi…
Almalki ZS; Imam MT; Ahmed NJ; Ghanem RK; S Alanazi T; Juweria S; Alanazi TS; Alqadhibi RB; Alsaleh S; Hasino FH; Saad Alsffar A; I Alzarea A; Albassam AA; Alshehri AM; Alahmari AK; Alem GM; Alalwan AA; Alamer A.
Saudi Pharm J (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Development, validation and measurement of patient satisfaction questionnaire in Spanish in drive thru services adapted…
Romero-Ibarguengoitia ME; López-Zamarrón KY; Hernández-Treviño MG; Gutierrez-González D; González-Cantú A; González Peña OI; Garza-Silva A.
Saudi Pharm J (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Inhibition of SARS-CoV-2 NSP-15 by Uridine-5'-Monophosphate Analogues Using QSAR Modelling, Molecular Dynamics Simulati…
Alshahrani MM.
Saudi Pharm J (Unknown)
Published: 2023
4/6 Transparent
Data Funding Declared
Assessment of clinical miscoding errors and potential financial their implications on healthcare management - A case of…
Albagmi S; Shawaheen M; Asiri EM; Alqadeer TA.
Saudi Pharm J (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Molecular docking, drug-likeness and DFT study of some modified tetrahydrocurcumins as potential anticancer agents.
Mahal A; Al-Janabi M; Eyüpoğlu V; Alkhouri A; Chtita S; Kadhim MM; Obaidullah AJ; Alotaibi JM; Wei X; Pratama MRF.
Saudi Pharm J (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Cost-Consequence Analysis of Colon Cancer Screening among Patients with Long-Standing Ulcerative Colitis: 11 Years' Exp…
Azzam N; Almadi M; Altuwaijiri M; Alharbi O; Aljebreen A; Alshankiti S; Alruthia Y.
Saudi Pharm J (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Efficacy of docetaxel, cisplatin, and 5-fluorouracil as an induction chemotherapy in oral squamous cell carcinoma in a …
Alessa M; Alhifany AA; Almatrafi NA; Bahaj AS; Alkaf HH; Alharbi J; Almaghrabi MY; Alsubaie HM; Elkhatib H; Albadainah F; Abdelmonim S.
Saudi Pharm J (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Exploring LIPIDs for their potential to improves bioavailability of lipophilic drugs candidates: A review.
Preeti; Sambhakar S; Saharan R; Narwal S; Malik R; Gahlot V; Khalid A; Najmi A; Zoghebi K; Halawi MA; Albratty M; Mohan S.
Saudi Pharm J (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Flipped classrooms in pharmacy education: A systematic review.
Aljaber N; Alsaidan J; Shebl N; Almanasef M.
Saudi Pharm J (Unknown)
Published: 2023
3/6 Transparent
Data
Cardioprotective study of <i>Eriobotrya japonica</i> leaf extracts against carbon tetrachloride induced toxicity in rat…
Shahat AA; Ullah R; Alqahtani AS; Fantoukh OI.
Saudi Pharm J (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Prescribing pattern of antipsychotics for patients with schizophrenia using the total daily dose online tool.
Alsabhan JF; Almalag HM; Aljafali L; Alnughamish H; Almutlaq G.
Saudi Pharm J (Unknown)
Published: 2023
5/6 Transparent
Data Code Funding Declared
3D QSAR study on substituted 1, 2, 4 triazole derivatives as anticancer agents by kNN MFA approach.
Desai SP; Mohite SK; Alobid S; Saralaya MG; Patil AS; Das K; Almadani ME; Arif Hussain S; Hussain Alamer B; Abdulrahman Jibreel E; Ibrahim Almoteer A; Mohammed Basheeruddin Asdaq S.
Saudi Pharm J (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
The impact of a restricted pregabalin prescription policy on drug utilization: An observational multicenter study.
Al-Jedai A; Alkofide H; Almohimeed L; Alsalim L; Alruwaili A; Alissa DA; Almudaiheem H.
Saudi Pharm J (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
A preparation technology of volatile components in Linggui Zhugan decoction based on the transfer of cinnamaldehyde and…
Li L; Wang N; Fan X; He N; Zhang T.
Saudi Pharm J (Unknown)
Published: 2023
3/6 Transparent
Funding Declared